Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019849143> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2019849143 abstract "as amifostine, glutathione, mesna, and dexrazoxane have been investigated and shown to provide drug-dependent protection to specific tissues, but the use of these compounds has not been shown to increase disease-free or overall survival. We previously showed that fasting selectively protects mice, and possibly patients, but not tumors against high-dose chemotherapy (Differential Stress Resistance, DSR). Here we show that the beneficial effect of fasting extends beyond protecting normal cells to sensitizing malignant cells to chemotherapy. Further, we show that the differential protection of normal cells and sensitization of malignant cells by fasting is mediated by reduced IGF-I levels/signaling. A 72-hour fast provided remarkable protection against doxorubicin. We observed that fasting reduced circulating IGF-I by 70% and increased the level of the IGF-I inhibitor IGFBP-1 by 11-fold in mice. LID mice, with a 70–80% reduction in circulating IGF-I levels, were protected against 3 out of 4 chemotherapy drugs tested. Restoration of IGF-I during fasting was sufficient to reverse its protective effect. 60% of melanoma-bearing LID mice treated with doxorubicin reached long-term survival whereas all control mice died of either metastases or chemotoxicity. In both our fasted (72 hours) and LID mice, we observed a 40% decrease in IGFBP-3 levels. Therefore, to test if reduced IGFBP-3 levels mediated DSR, we challenge transgenic IGFBP-3 knockout mice (IGFBP3KO) with cyclophosphamide. We found no significant difference in survival between WT and IGFBP3KO mice, suggesting a larger role of IGF-I in mediating DSR independently of IGFBP-3. Reduction of IGF-I/IGF-I signaling protected primary glia, but not glioma cells against cyclophosphamide and protected mouse embryonic fibroblasts (MEFs) against doxorubicin-induced DNA damage. On the contrary, in malignant cells, the addition of IGF-I during fasting was sufficient to reverse the sensitization to chemotherapy in vitro. Similarly, S. cerevisiae lacking homologues of IGF-I signaling proteins displayed protection against chemotherapydependent DNA damage, which was reversed by expression of an oncogene homolog. Our studies suggest that fasting has the potential to protect patients and sensitize cancer cells, in part, by reducing IGF-I levels/signaling, thereby increasing the therapeutic index of toxic drugs commonly used in the treatment of a wide range of malignancies." @default.
- W2019849143 created "2016-06-24" @default.
- W2019849143 creator A5005698080 @default.
- W2019849143 creator A5019707272 @default.
- W2019849143 creator A5027462458 @default.
- W2019849143 creator A5029324480 @default.
- W2019849143 creator A5062399385 @default.
- W2019849143 creator A5065571043 @default.
- W2019849143 creator A5087579079 @default.
- W2019849143 creator A5090899482 @default.
- W2019849143 date "2010-01-01" @default.
- W2019849143 modified "2023-09-26" @default.
- W2019849143 title "OR13,77 Insulin-like growth factors (IGFs) and IGF binding proteins in PSA-detected prostate cancer: a population-based case control study" @default.
- W2019849143 doi "https://doi.org/10.1016/s1096-6374(10)70093-9" @default.
- W2019849143 hasPublicationYear "2010" @default.
- W2019849143 type Work @default.
- W2019849143 sameAs 2019849143 @default.
- W2019849143 citedByCount "0" @default.
- W2019849143 crossrefType "journal-article" @default.
- W2019849143 hasAuthorship W2019849143A5005698080 @default.
- W2019849143 hasAuthorship W2019849143A5019707272 @default.
- W2019849143 hasAuthorship W2019849143A5027462458 @default.
- W2019849143 hasAuthorship W2019849143A5029324480 @default.
- W2019849143 hasAuthorship W2019849143A5062399385 @default.
- W2019849143 hasAuthorship W2019849143A5065571043 @default.
- W2019849143 hasAuthorship W2019849143A5087579079 @default.
- W2019849143 hasAuthorship W2019849143A5090899482 @default.
- W2019849143 hasConcept C121608353 @default.
- W2019849143 hasConcept C126322002 @default.
- W2019849143 hasConcept C134018914 @default.
- W2019849143 hasConcept C2776694085 @default.
- W2019849143 hasConcept C2776755627 @default.
- W2019849143 hasConcept C2779387952 @default.
- W2019849143 hasConcept C2780192828 @default.
- W2019849143 hasConcept C2781303535 @default.
- W2019849143 hasConcept C502942594 @default.
- W2019849143 hasConcept C71924100 @default.
- W2019849143 hasConceptScore W2019849143C121608353 @default.
- W2019849143 hasConceptScore W2019849143C126322002 @default.
- W2019849143 hasConceptScore W2019849143C134018914 @default.
- W2019849143 hasConceptScore W2019849143C2776694085 @default.
- W2019849143 hasConceptScore W2019849143C2776755627 @default.
- W2019849143 hasConceptScore W2019849143C2779387952 @default.
- W2019849143 hasConceptScore W2019849143C2780192828 @default.
- W2019849143 hasConceptScore W2019849143C2781303535 @default.
- W2019849143 hasConceptScore W2019849143C502942594 @default.
- W2019849143 hasConceptScore W2019849143C71924100 @default.
- W2019849143 hasLocation W20198491431 @default.
- W2019849143 hasOpenAccess W2019849143 @default.
- W2019849143 hasPrimaryLocation W20198491431 @default.
- W2019849143 hasRelatedWork W1974610195 @default.
- W2019849143 hasRelatedWork W1978050061 @default.
- W2019849143 hasRelatedWork W2007225715 @default.
- W2019849143 hasRelatedWork W2014955320 @default.
- W2019849143 hasRelatedWork W2034329247 @default.
- W2019849143 hasRelatedWork W2065037425 @default.
- W2019849143 hasRelatedWork W2068995799 @default.
- W2019849143 hasRelatedWork W2070277316 @default.
- W2019849143 hasRelatedWork W2072139215 @default.
- W2019849143 hasRelatedWork W2088524487 @default.
- W2019849143 hasRelatedWork W2151472455 @default.
- W2019849143 hasRelatedWork W2156205243 @default.
- W2019849143 hasRelatedWork W2350284936 @default.
- W2019849143 hasRelatedWork W2352573736 @default.
- W2019849143 hasRelatedWork W2377090943 @default.
- W2019849143 hasRelatedWork W2460096751 @default.
- W2019849143 hasRelatedWork W2889108995 @default.
- W2019849143 hasRelatedWork W2995497148 @default.
- W2019849143 hasRelatedWork W3206657973 @default.
- W2019849143 hasRelatedWork W2086363055 @default.
- W2019849143 isParatext "false" @default.
- W2019849143 isRetracted "false" @default.
- W2019849143 magId "2019849143" @default.
- W2019849143 workType "article" @default.